People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Other Technology, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SnapMD, Inc. | — | Other Technology | Series A | $18.7M | $197.6M | 2013 |
| Nemus | — | Pharmaceuticals | Seed | $1.9M | $17.3M | 2014 |
| FiberX Inc. | — | Other | Pre-Seed | $621K | $2.6M | 2023 |
David Skibinski at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Skibinski on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Murphy | 1 | 15 |
| Doug Campbell | 1 | 3 |
| David Lam | 1 | 3 |
| Douglas Campbell | 1 | 3 |
| John Hollister | 1 | 2 |
| Jerry McLaughlin | 1 | 1 |
| Wade Lang | 1 | 1 |
| Richard P. Boutin | 1 | 1 |
| David T. Lam | 1 | 1 |
| George Tierney | 1 | 1 |
| Elizabeth Berecz | 1 | 1 |
| Cosmas Lykos | 1 | 1 |
| Reg Lapham | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.